ArticleMolecular therapy. Nucleic acids2022

Improved loss-of-function CRISPR-Cas9 genome editing in human cells concomitant with inhibition of TGF-β signaling.

Tarun Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.